Vernal Keratoconjunctiviti (VKC) is a chronic allergic eye condition that can cause inflammation and discomfort. Anti-inflammatory medications are a commonly prescribed treatment option for VKC patients. Topical corticosteroids are often used to reduce inflammation in the eyes, and can be effective in relieving symptoms such as itching, redness, and swelling. However, long-term use of these medications can have side effects such as increased eye pressure, cataracts, and increased risk of infections.
Other anti-inflammatory medications used to treat Vernal Keratoconjunctivitis include topical calcineurin inhibitors, which work by suppressing the immune response in the eyes. These medications can be effective in reducing inflammation and improving symptoms, but may also have side effects such as burning and stinging. In addition to topical medications, systemic immunosuppressive agents may also be used to manage severe VKC. These medications work by suppressing the immune system, but may also have significant side effects and require close monitoring.